{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:24:36Z","timestamp":1793319876643,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-023-02833-7","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T07:02:47Z","timestamp":1685430167000},"page":"291-300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Machine learning analyses constructed a novel model to predict recurrent thrombosis in adults with essential thrombocythemia"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7096-1056","authenticated-orcid":false,"given":"Jia","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1783-711X","authenticated-orcid":false,"given":"Huan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongfeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mankai","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3741-8518","authenticated-orcid":false,"given":"Renchi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7769-7377","authenticated-orcid":false,"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"issue":"12","key":"2833_CR1","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/ajh.26008","volume":"95","author":"A Tefferi","year":"2020","unstructured":"Tefferi A, Barbui T (2020) Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management. Am J Hematol 95(12):1599\u20131613. https:\/\/doi.org\/10.1002\/ajh.26008","journal-title":"Am J Hematol"},{"issue":"1","key":"2833_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1182\/bloodadvances.2020003628","volume":"5","author":"EN Hamulyak","year":"2021","unstructured":"Hamulyak EN, Daams JG, Leebeek FWG, Biemond BJ, Te Boekhorst PAW, Middeldorp S, Lauw MN (2021) A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms. Blood Adv 5(1):113\u2013121. https:\/\/doi.org\/10.1182\/bloodadvances.2020003628","journal-title":"Blood Adv"},{"issue":"3","key":"2833_CR3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3324\/haematol.12053","volume":"93","author":"V De Stefano","year":"2008","unstructured":"De Stefano V, Za T, Rossi E, Vannucchi AM, Ruggeri M, Elli E, Mico C, Tieghi A, Cacciola RR, Santoro C, Gerli G, Vianelli N, Guglielmelli P, Pieri L, Scognamiglio F, Rodeghiero F, Pogliani EM, Finazzi G, Gugliotta L, Marchioli R, Leone G, Barbui T, Party (2008) Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. Haematologica 93(3):372\u2013380. https:\/\/doi.org\/10.3324\/haematol.12053. GC-W(","journal-title":"Haematologica"},{"issue":"10","key":"2833_CR4","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/leu.2016.85","volume":"30","author":"V De Stefano","year":"2016","unstructured":"De Stefano V, Ruggeri M, Cervantes F, Alvarez-Larran A, Iurlo A, Randi ML, Elli E, Finazzi MC, Finazzi G, Zetterberg E, Vianelli N, Gaidano G, Rossi E, Betti S, Nichele I, Cattaneo D, Palova M, Ellis MH, Cacciola R, Tieghi A, Hernandez-Boluda JC, Pungolino E, Specchia G, Rapezzi D, Forcina A, Musolino C, Carobbio A, Griesshammer M, Sant\u2019Antonio E, Vannucchi AM, Barbui T (2016) High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists. Leukemia 30(10):2032\u20132038. https:\/\/doi.org\/10.1038\/leu.2016.85","journal-title":"Leukemia"},{"issue":"26","key":"2833_CR5","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1182\/blood-2012-07-444067","volume":"120","author":"T Barbui","year":"2012","unstructured":"Barbui T, Finazzi G, Carobbio A, Thiele J, Passamonti F, Rumi E, Ruggeri M, Rodeghiero F, Randi ML, Bertozzi I, Gisslinger H, Buxhofer-Ausch V, De Stefano V, Betti S, Rambaldi A, Vannucchi AM, Tefferi A (2012) Development and validation of an International Prognostic score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis). Blood 120(26):5128\u20135133 quiz 5252. https:\/\/doi.org\/10.1182\/blood-2012-07-444067","journal-title":"Blood"},{"issue":"3","key":"2833_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41408-018-0048-9","volume":"8","author":"V De Stefano","year":"2018","unstructured":"De Stefano V, Carobbio A, Di Lazzaro V, Guglielmelli P, Iurlo A, Finazzi MC, Rumi E, Cervantes F, Elli EM, Randi ML, Griesshammer M, Palandri F, Bonifacio M, Hernandez-Boluda JC, Cacciola R, Miroslava P, Carli G, Beggiato E, Ellis MH, Musolino C, Gaidano G, Rapezzi D, Tieghi A, Lunghi F, Loscocco GG, Cattaneo D, Cortelezzi A, Betti S, Rossi E, Finazzi G, Censori B, Cazzola M, Bellini M, Arellano-Rodrigo E, Bertozzi I, Sadjadian P, Vianelli N, Scaffidi L, Gomez M, Cacciola E, Vannucchi AM, Barbui T (2018) Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms. Blood Cancer J 8(3):25. https:\/\/doi.org\/10.1038\/s41408-018-0048-9","journal-title":"Blood Cancer J"},{"issue":"10236","key":"2833_CR7","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(20)30226-9","volume":"395","author":"N Schwalbe","year":"2020","unstructured":"Schwalbe N, Wahl B (2020) Artificial intelligence and the future of global health. Lancet 395(10236):1579\u20131586. https:\/\/doi.org\/10.1016\/S0140-6736(20)30226-9","journal-title":"Lancet"},{"key":"2833_CR8","doi-asserted-by":"publisher","first-page":"175628642211293","DOI":"10.1177\/17562864221129380","volume":"15","author":"J Liu","year":"2022","unstructured":"Liu J, Chen X, Guo X, Xu R, Wang Y, Liu M (2022) Machine learning prediction of symptomatic intracerebral hemorrhage after stroke thrombolysis: a cross-cultural validation in caucasian and Han Chinese cohort. Ther Adv Neurol Disord 15:17562864221129380. https:\/\/doi.org\/10.1177\/17562864221129380","journal-title":"Ther Adv Neurol Disord"},{"key":"2833_CR9","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/nbt1206-1565","volume":"24","author":"WS Noble","year":"2006","unstructured":"Noble WS (2006) What is a support vector machine? Nat Biotechnol 24:1565\u20131567","journal-title":"Nat Biotechnol"},{"issue":"12","key":"2833_CR10","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/s0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49(12):1373\u20131379. https:\/\/doi.org\/10.1016\/s0895-4356(96)00236-3","journal-title":"J Clin Epidemiol"},{"key":"2833_CR11","doi-asserted-by":"publisher","unstructured":"Barbui T, Falanga A (2016) Molecular biomarkers of thrombosis in myeloproliferative neoplasms. Thromb Res 140 Suppl 1 :S71-5. https:\/\/doi.org\/10.1016\/S0049-3848(16)30102-5","DOI":"10.1016\/S0049-3848(16)30102-5"},{"issue":"2","key":"2833_CR12","first-page":"215","volume":"89","author":"T Barbui","year":"2004","unstructured":"Barbui T, Barosi G, Grossi A, Gugliotta L, Liberato LN, Marchetti M, Mazzucconi MG, Rodeghiero F, Tura S (2004) Practice guidelines for the therapy of essential thrombocythemia. A statement from the italian society of Hematology, the italian society of experimental hematology and the Italian Group for Bone Marrow Transplantation. Haematologica 89(2):215\u2013232","journal-title":"Haematologica"},{"issue":"7","key":"2833_CR13","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, Bejar R, Berti E, Busque L, Chan JKC, Chen W, Chen X, Chng WJ, Choi JK, Colmenero I, Coupland SE, Cross NCP, De Jong D, Elghetany MT, Takahashi E, Emile JF, Ferry J, Fogelstrand L, Fontenay M, Germing U, Gujral S, Haferlach T, Harrison C, Hodge JC, Hu S, Jansen JH, Kanagal-Shamanna R, Kantarjian HM, Kratz CP, Li XQ, Lim MS, Loeb K, Loghavi S, Marcogliese A, Meshinchi S, Michaels P, Naresh KN, Natkunam Y, Nejati R, Ott G, Padron E, Patel KP, Patkar N, Picarsic J, Platzbecker U, Roberts I, Schuh A, Sewell W, Siebert R, Tembhare P, Tyner J, Verstovsek S, Wang W, Wood B, Xiao W, Yeung C, Hochhaus A (2022) The 5th edition of the World Health Organization classification of Haematolymphoid Tumours: myeloid and Histiocytic\/Dendritic neoplasms. Leukemia 36(7):1703\u20131719. https:\/\/doi.org\/10.1038\/s41375-022-01613-1","journal-title":"Leukemia"},{"key":"2833_CR14","doi-asserted-by":"publisher","unstructured":"Landolfi R, Marchioli R, Kutti J, Gisslinger H, Tognoni G, Patrono C, Barbui T European collaboration on low-dose aspirin in Polycythemia Vera I(2004). Efficacy and safety of low-dose aspirin in polycythemia vera. N Engl J Med 350(2):114\u201324. https:\/\/doi.org\/10.1056\/NEJMoa035572","DOI":"10.1056\/NEJMoa035572"},{"key":"2833_CR15","doi-asserted-by":"publisher","first-page":"b2393","DOI":"10.1136\/bmj.b2393","volume":"338","author":"JA Sterne","year":"2009","unstructured":"Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 338:b2393. https:\/\/doi.org\/10.1136\/bmj.b2393","journal-title":"BMJ"},{"key":"2833_CR16","doi-asserted-by":"publisher","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo (2015) RP Nomograms in oncology: more than meets the eye. Lancet Oncol. 16(4):e173-80. https:\/\/doi.org\/10.1016\/S1470-2045(14)71116-7","DOI":"10.1016\/S1470-2045(14)71116-7"},{"issue":"5","key":"2833_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7326\/M17-0028","volume":"168","author":"M Hultcrantz","year":"2018","unstructured":"Hultcrantz M, Bjorkholm M, Dickman PW, Landgren O, Derolf AR, Kristinsson SY, Andersson TML (2018) Risk for arterial and venous thrombosis in patients with myeloproliferative neoplasms: a Population-Based Cohort Study. Ann Intern Med 168(5):317\u2013325. https:\/\/doi.org\/10.7326\/M17-0028","journal-title":"Ann Intern Med"},{"issue":"11","key":"2833_CR18","doi-asserted-by":"publisher","first-page":"e369","DOI":"10.1038\/bcj.2015.94","volume":"5","author":"T Barbui","year":"2015","unstructured":"Barbui T, Vannucchi AM, Buxhofer-Ausch V, De Stefano V, Betti S, Rambaldi A, Rumi E, Ruggeri M, Rodeghiero F, Randi ML, Bertozzi I, Gisslinger H, Finazzi G, Carobbio A, Thiele J, Passamonti F, Falcone C, Tefferi A (2015) Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia. Blood Cancer J 5(11):e369. https:\/\/doi.org\/10.1038\/bcj.2015.94","journal-title":"Blood Cancer J"},{"issue":"22","key":"2833_CR19","doi-asserted-by":"publisher","first-page":"5857","DOI":"10.1182\/blood-2011-02-339002","volume":"117","author":"A Carobbio","year":"2011","unstructured":"Carobbio A, Thiele J, Passamonti F, Rumi E, Ruggeri M, Rodeghiero F, Randi ML, Bertozzi I, Vannucchi AM, Antonioli E, Gisslinger H, Buxhofer-Ausch V, Finazzi G, Gangat N, Tefferi A, Barbui T (2011) Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients. Blood 117(22):5857\u20135859. https:\/\/doi.org\/10.1182\/blood-2011-02-339002","journal-title":"Blood"},{"issue":"2","key":"2833_CR20","doi-asserted-by":"publisher","first-page":"E37","DOI":"10.1002\/ajh.26402","volume":"97","author":"BN Reeves","year":"2022","unstructured":"Reeves BN, Kim SJ, Song J, Wilson KJ, Henderson MW, Key NS, Pawlinski R, Prchal JT (2022) Tissue factor activity is increased in neutrophils from JAK2 V617F-mutated essential thrombocythemia and polycythemia vera patients. Am J Hematol 97(2):E37\u2013E40. https:\/\/doi.org\/10.1002\/ajh.26402","journal-title":"Am J Hematol"},{"issue":"2","key":"2833_CR21","doi-asserted-by":"publisher","first-page":"E35","DOI":"10.1002\/ajh.26423","volume":"97","author":"F Farrukh","year":"2022","unstructured":"Farrukh F, Guglielmelli P, Loscocco GG, Pardanani A, Hanson CA, De Stefano V, Barbui T, Gangat N, Vannucchi AM, Tefferi A (2022) Deciphering the individual contribution of absolute neutrophil and monocyte counts to thrombosis risk in polycythemia vera and essential thrombocythemia. Am J Hematol 97(2):E35\u2013E37. https:\/\/doi.org\/10.1002\/ajh.26423","journal-title":"Am J Hematol"},{"issue":"22","key":"2833_CR22","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1182\/blood.2021011494","volume":"138","author":"MS Edvardsen","year":"2021","unstructured":"Edvardsen MS, Hansen ES, Hindberg K, Morelli VM, Ueland T, Aukrust P, Braekkan SK, Evensen LH, Hansen JB (2021) Combined effects of plasma von willebrand factor and platelet measures on the risk of incident venous thromboembolism. Blood 138(22):2269\u20132277. https:\/\/doi.org\/10.1182\/blood.2021011494","journal-title":"Blood"},{"issue":"9","key":"2833_CR23","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1182\/bloodadvances.2020003377","volume":"5","author":"J Campos","year":"2021","unstructured":"Campos J, Ponomaryov T, De Prendergast A, Whitworth K, Smith CW, Khan AO, Kavanagh D, Brill A (2021) Neutrophil extracellular traps and inflammasomes cooperatively promote venous thrombosis in mice. Blood Adv 5(9):2319\u20132324. https:\/\/doi.org\/10.1182\/bloodadvances.2020003377","journal-title":"Blood Adv"},{"issue":"2","key":"2833_CR24","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41375-021-01410-2","volume":"36","author":"D Liu","year":"2022","unstructured":"Liu D, Li B, Xu Z, Zhang P, Qin T, Qu S, Pan L, Sun X, Shi Z, Huang H, Wang H, Gale RP, Xiao Z (2022) RBC distribution width predicts thrombosis risk in polycythemia vera. Leukemia 36(2):566\u2013568. https:\/\/doi.org\/10.1038\/s41375-021-01410-2","journal-title":"Leukemia"},{"key":"2833_CR25","doi-asserted-by":"publisher","first-page":"102368","DOI":"10.1016\/j.bcmd.2019.102368","volume":"80","author":"I Krecak","year":"2020","unstructured":"Krecak I, Krecak F, Gveric-Krecak V (2020) High red blood cell distribution width might predict thrombosis in essential thrombocythemia and polycythemia vera. Blood Cells Mol Dis 80:102368. https:\/\/doi.org\/10.1016\/j.bcmd.2019.102368","journal-title":"Blood Cells Mol Dis"},{"issue":"10","key":"2833_CR26","doi-asserted-by":"publisher","first-page":"E402","DOI":"10.3978\/j.issn.2072-1439.2015.10.04","volume":"7","author":"E Danese","year":"2015","unstructured":"Danese E, Lippi G, Montagnana M (2015) Red blood cell distribution width and cardiovascular diseases. J Thorac Dis 7(10):E402\u2013E411. https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2015.10.04","journal-title":"J Thorac Dis"},{"key":"2833_CR27","doi-asserted-by":"publisher","unstructured":"Liu W, Ostberg N, Yalcinkaya M, Dou H, Endo-Umeda K, Tang Y, Hou X, Xiao T, Fidler TP, Abramowicz S, Yang YG, Soehnlein O, Tall AR, Wang N (2022) Erythroid lineage Jak2V617F expression promotes atherosclerosis through erythrophagocytosis and macrophage ferroptosis. J Clin Invest 132(13). https:\/\/doi.org\/10.1172\/JCI155724","DOI":"10.1172\/JCI155724"},{"key":"2833_CR28","doi-asserted-by":"publisher","unstructured":"Horne BD, Muhlestein JB, Bennett ST, Muhlestein JB, Jensen KR, Marshall D, Bair TL, May HT, Carlquist JF, Hegewald M, Knight S, Le VT, Bunch TJ, Lappe DL, Anderson JL, Knowlton KU (2018) Extreme erythrocyte macrocytic and microcytic percentages are highly predictive of morbidity and mortality. JCI Insight 3(14). https:\/\/doi.org\/10.1172\/jci.insight.120183","DOI":"10.1172\/jci.insight.120183"},{"key":"2833_CR29","doi-asserted-by":"publisher","unstructured":"Mascarenhas J, Kosiorek HE, Josef T, Prchal A, Rambaldi D, Berenzon A, Yacoub CN, Harrison, McMullin (2022) MF A randomized phase 3 trial of interferon-\u03b1 vs hydroxyurea in polycythemia vera and essential thrombocythemia. Blood. 139(19):2931\u20132941. https:\/\/doi.org\/10.1016\/S2352-3026(21)00343-4","DOI":"10.1016\/S2352-3026(21)00343-4"},{"issue":"12","key":"2833_CR30","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41408-017-0035-6","volume":"7","author":"S Cerquozzi","year":"2017","unstructured":"Cerquozzi S, Barraco D, Lasho T, Finke C, Hanson CA, Ketterling RP, Pardanani A, Gangat N, Tefferi A (2017) Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients. Blood Cancer J 7(12):662. https:\/\/doi.org\/10.1038\/s41408-017-0035-6","journal-title":"Blood Cancer J"},{"key":"2833_CR31","doi-asserted-by":"publisher","unstructured":"Wang Z, Liu W, Wang D, Yang E, Li Y, Li Y, Sun Y, Wang M, Lv Y, Hu X (2022) TET2 mutation may be more Valuable in Predicting thrombosis in ET Patients compared to PV patients: a preliminary Report. J Clin Med 11(22). https:\/\/doi.org\/10.3390\/jcm11226615","DOI":"10.3390\/jcm11226615"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02833-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-023-02833-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02833-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T03:22:23Z","timestamp":1689132143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-023-02833-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["2833"],"URL":"https:\/\/doi.org\/10.1007\/s11239-023-02833-7","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"assertion":[{"value":"16 May 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Ethics Committee of the Institute of Hematology & Blood Diseases Hospital of the Chinese Academy of Medical Sciences.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study obtained informed written consent from the patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}]}}